These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7486681)

  • 21. E7080, a novel inhibitor that targets multiple kinases, has potent antitumor activities against stem cell factor producing human small cell lung cancer H146, based on angiogenesis inhibition.
    Matsui J; Yamamoto Y; Funahashi Y; Tsuruoka A; Watanabe T; Wakabayashi T; Uenaka T; Asada M
    Int J Cancer; 2008 Feb; 122(3):664-71. PubMed ID: 17943726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fyn kinase acts upstream of Shp2 and p38 mitogen-activated protein kinase to promote chemotaxis of mast cells towards stem cell factor.
    Samayawardhena LA; Hu J; Stein PL; Craig AW
    Cell Signal; 2006 Sep; 18(9):1447-54. PubMed ID: 16442778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dimerization of cell surface receptors in signal transduction.
    Heldin CH
    Cell; 1995 Jan; 80(2):213-23. PubMed ID: 7834741
    [No Abstract]   [Full Text] [Related]  

  • 24. Identifying Residues that Determine SCF Molecular-Level Interactions through a Combination of Experimental and In silico Analyses.
    Rabinovich E; Heyne M; Bakhman A; Kosloff M; Shifman JM; Papo N
    J Mol Biol; 2017 Jan; 429(1):97-114. PubMed ID: 27890784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphorylation in the activation loop as the finishing touch in c-Kit activation.
    Miyazawa K
    J Biochem; 2012 May; 151(5):457-9. PubMed ID: 22437942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural aspects of cytokine/receptor interactions.
    Nicola NA
    Ann N Y Acad Sci; 1995 Sep; 766():253-62. PubMed ID: 7486668
    [No Abstract]   [Full Text] [Related]  

  • 27. Signaling by Kit protein-tyrosine kinase--the stem cell factor receptor.
    Roskoski R
    Biochem Biophys Res Commun; 2005 Nov; 337(1):1-13. PubMed ID: 16129412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of spontaneous receptor phosphorylation by residues in a putative alpha-helix in the KIT intracellular juxtamembrane region.
    Ma Y; Cunningham ME; Wang X; Ghosh I; Regan L; Longley BJ
    J Biol Chem; 1999 May; 274(19):13399-402. PubMed ID: 10224103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Normal and oncogenic forms of the receptor tyrosine kinase kit.
    Lennartsson J; Jelacic T; Linnekin D; Shivakrupa R
    Stem Cells; 2005; 23(1):16-43. PubMed ID: 15625120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stem cell factor augments Fc epsilon RI-mediated TNF-alpha production and stimulates MAP kinases via a different pathway in MC/9 mast cells.
    Ishizuka T; Kawasome H; Terada N; Takeda K; Gerwins P; Keller GM; Johnson GL; Gelfand EW
    J Immunol; 1998 Oct; 161(7):3624-30. PubMed ID: 9759885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3D QSAR studies on a series of potent and high selective inhibitors for three kinases of RTK family.
    Cao H; Zhang H; Zheng X; Gao D
    J Mol Graph Model; 2007 Jul; 26(1):236-45. PubMed ID: 17293140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Receptor tyrosine kinases (c-kit, c-fmns, Flt-3, Tie2, etc.)].
    Yoshimura A; Sanada M; Mashima R
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():207-14. PubMed ID: 15861658
    [No Abstract]   [Full Text] [Related]  

  • 33. The fifth immunoglobulin-like domain of the Kit receptor is required for proteolytic cleavage from the cell surface.
    Broudy VC; Lin NL; Sabath DF
    Cytokine; 2001 Aug; 15(4):188-95. PubMed ID: 11563879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of c-kit/SCF in cause and treatment of gastrointestinal stromal tumors (GIST).
    Ali S; Ali S
    Gene; 2007 Oct; 401(1-2):38-45. PubMed ID: 17659849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The adapter protein APS associates with the multifunctional docking sites Tyr-568 and Tyr-936 in c-Kit.
    Wollberg P; Lennartsson J; Gottfridsson E; Yoshimura A; Rönnstrand L
    Biochem J; 2003 Mar; 370(Pt 3):1033-8. PubMed ID: 12444928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The selective class III/V receptor tyrosine kinase inhibitor SU11657 inhibits tumor growth and angiogenesis in experimental neuroblastomas grown in mice.
    Bäckman U; Christofferson R
    Pediatr Res; 2005 May; 57(5 Pt 1):690-5. PubMed ID: 15718357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Receptor tyrosine kinase Kit action in skin melanocytes: is it exclusively cell autonomous?
    Li H; Hou L
    Exp Dermatol; 2015 Dec; 24(12):920-1. PubMed ID: 26268458
    [No Abstract]   [Full Text] [Related]  

  • 38. SCF and c-kit in mastocytosis--a Pandora's box holding more theories than proven facts.
    Henz BM
    J Invest Dermatol; 1998 Feb; 110(2):186-7. PubMed ID: 9457920
    [No Abstract]   [Full Text] [Related]  

  • 39. The Proto-oncogene c-Kit Inhibits Tumor Growth by Behaving as a Dependence Receptor.
    Wang H; Boussouar A; Mazelin L; Tauszig-Delamasure S; Sun Y; Goldschneider D; Paradisi A; Mehlen P
    Mol Cell; 2018 Nov; 72(3):413-425.e5. PubMed ID: 30293784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.
    Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C
    Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.